Table 2 Binding affinities and thermostability of the mutant clones selected by yeast display
From: SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
Clone | Library | Plasmida | Mutations | Tm (°C) | KD,YD (pM)c | KD (M)d | kon (M−1s−1) | koff (s−1) | Chi² (RU²) |
RBD-WT | pJYDC1 | Residues 336–528 | 53.9 | 1,700 ± 137 [8] | 1.7 × 10−8 | 4.5 × 105 | 7.6 × 10−3 | 0.222 | |
RBD-32 | B3 | pJYDC1 | I358F, S477N, N501Y | ND | 348 ± 35 [3] | ND | |||
RBD-33 | B3 | pJYDC1 | I358F, E484K, N501Y | ND | 204 ± 88 [4] | ND | |||
RBD-36 | B3 | pJYDC1 | I358F, I468T, N481Y, N501Y | 54.6 | 268 ± 35 [3] | 1.0 × 10−8 | 2.1 × 105 | 2.2 × 10−3 | 0.119 |
RBD-48 | B4 | pJYDC3 | I358F, E484K, Q498R, N501Y | 54.8 | 55 ± 23 [4] | 1.7 × 10−10 | 1.0 × 106 | 1.7 × 10−4 | 0.182 |
RBD-52 | B5 | pJYDC1 | I358F, N460K, E484K, S494P, Q498R, N501Y, A520G | 61.9 | 40 ± 16 [5] | 2.4 × 10−10 | 3.8 × 105 | 9.0 × 10−5 | 0.0515 |
RBD-521 | B5 | pJYDC1 | I358F, N460K, E484K, Q498R, N501Y | 58.3 | 14 ± 3 [3] | 1.7 × 10−10 | 9.0 × 105 | 1.6 × 10−4 | 0.0562 |
RBD-62 | B6(FA) | pJYDC3 | I358F, V445K, N460K, I468T, T470M, S477N, E484K, Q498R, N501Y | 57.6 | 3.5 ± 1.8 [4] | 1.6 × 10−11 | 4.4 × 106 | 6.8 × 10−5 | 0.42 |
RBD-614 | B6(FA) | pJYDC3 | I358F, V445K, N460K, E484K, S494P, Q498R, N501Y | 58.5 | 21 ± 6.2 [3] | 1.9 × 10−10 | 6.8 × 105 | 1.3 × 10−4 | 0.0488 |
RBD-71 | pJYDC3 | I358F, V367W, R408D, K417V, V445K, N460K, I468T, T470M, S477N, E484K, Q498R, N501Y | 63.5 | 8.5 ± 2.5 [3] | 1.6 × 10−10 | 1.2 × 106 | 2.0 × 10−4 | 0.104 |